Swaraj Suiting Fund Raise of ₹174.2 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting allotted 4,65,000 equity shares to five investors under a preferential issue at Rs.236 each. The allotment raised about Rs.10.97 Crore.

Value

₹10.97 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting Limited allotted securities under a preferential issue, filed on BSE XBRL on 30 October 2026. The filing gives share counts but no explicit consideration for this allotment.

Swaraj Suiting Convertible Warrants

Swaraj Suiting allotted 4,65,000 shares on warrant conversion for Rs 8.23 Crore cash. Paid-up capital rises to Rs 26.88 Crore.

Value

₹8.23 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting held its EGM on 24 October 2026 to seek approval for a preferential issue of 35 lakh equity shares and 17 lakh convertible warrants at Rs.335 each. Voting results will be filed separately.

Value

₹174.2 Cr

Swaraj Suiting Preferential Issue

Swaraj Suiting issued a corrigendum amending the explanatory statement of its EGM notice regarding a Rs. 117.25 Crore preferential issue to investors.

Value

₹117.2 Cr

Swaraj Suiting Other Announcement

Swaraj Suiting Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.